机译:卡波替尼治疗晚期甲状腺髓样癌
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., Mail Code 1027, Chicago, IL, 60645, USA;
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., Mail Code 1027, Chicago, IL, 60645, USA;
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., Mail Code 1027, Chicago, IL, 60645, USA;
Cabozantinib; Endocrinology; Medullary thyroid cancer; Oncology; Targeted therapy; Tyrosine kinase inhibitors;
机译:卡波替尼(XL184)用于治疗局部晚期或转移性进行性甲状腺髓样癌
机译:卡博替尼的概况及其在晚期甲状腺髓样癌治疗中的潜力
机译:卡波替尼用于治疗晚期甲状腺髓样癌。
机译:切尔诺贝利事故后白俄罗斯儿童放射性碘治疗的结果
机译:Notch3信号传导的靶向活化在晚期甲状腺癌的治疗中。
机译:卡博替尼的概况及其在晚期甲状腺髓样癌治疗中的潜力
机译:Cabozantinib概况及其在治疗晚期髓质甲状腺癌中的潜力